Literature DB >> 3143690

T1-T2 squamous cell carcinoma of the glottic larynx treated with radiation therapy: relationship of dose-fractionation factors to local control and complications.

W M Mendenhall1, J T Parsons, R R Million, G H Fletcher.   

Abstract

This is an analysis of 304 patients with invasive, previously untreated T1-T2 squamous cell carcinoma of the glottic larynx treated with radiation therapy at the University of Florida between October 1964 and December 1984. All patients had a minimum 2-year follow-up and 82% had at least 5 years of follow-up. Patients were excluded from the analysis of local control if they died within 2 years of treatment with the primary site continuously disease-free; all patients were included in the analysis of treatment complications. Patients were staged according to the 1983 AJCC system. Stage T2 was subdivided into 2 groups as follows: T2a (normal mobility) and T2b (decreased mobility). The rates of local control with radiation therapy were as follows: T1, 159/171 (93%); T2a, 50/65 (77%); and T2b, 31/43 (72%). Patients were further divided into subsets based on T stage and the surgical procedure that would have been required to resect the lesion. Local control was noted to improve with higher doses and dose per fraction in 4 of 7 subsets. In 2 of 3 subsets where a dose-fractionation relationship was not observed, there were no local recurrences in 1 subset and only 2 local recurrences in the other. The overall incidence of serious complications was 5/304 (1.6%) and was associated with T stage and with increasing total dose and dose per fraction.

Entities:  

Mesh:

Year:  1988        PMID: 3143690     DOI: 10.1016/0360-3016(88)90220-9

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  13 in total

Review 1.  Early laryngeal cancer.

Authors:  Russell W Hinerman; William M Mendenhall; Robert J Amdur; Douglas B Villaret; K Thomas Robbins
Journal:  Curr Treat Options Oncol       Date:  2002-02

2.  [Non- inferior moderate hypofractionated irradiation of glottis T1/T2 laryngeal cancer ].

Authors:  Martina Becker-Schiebe; Hans Christiansen
Journal:  Strahlenther Onkol       Date:  2014-07       Impact factor: 3.621

3.  An investigation of intensity-modulated radiation therapy versus conventional two-dimensional and 3D-conformal radiation therapy for early stage larynx cancer.

Authors:  Daniel Gomez; Oren Cahlon; James Mechalakos; Nancy Lee
Journal:  Radiat Oncol       Date:  2010-08-26       Impact factor: 3.481

4.  Outcomes after radiation therapy for T2N0/stage II glottic squamous cell carcinoma.

Authors:  Karine A Al Feghali; Bassem Y Youssef; Abdallah S R Mohamed; Lara Hilal; Blaine D Smith; Ibrahim Abu-Gheida; Georges Farha; G Brandon Gunn; Jack Phan; Jan Lewin; Apurva Thekdi; William H Morrison; Adam S Garden; Clifton David Fuller; David I Rosenthal
Journal:  Head Neck       Date:  2020-06-02       Impact factor: 3.147

5.  Predictive factors for local control of early glottic squamous cell carcinomas after definitive radiotherapy.

Authors:  Mitsuru Okubo; Tomohiro Itonaga; Tatsuhiko Saito; Sachika Shiraishi; Ryuji Mikami; Akira Sakurada; Shinji Sugahara; Jinho Park; Koichi Tokuuye; Kazuhiro Saito
Journal:  Mol Clin Oncol       Date:  2020-03-30

6.  Impact and relationship of anterior commissure and time-dose factor on the local control of T1N0 glottic cancer treated by 6 MV photons.

Authors:  Chi-Chung Tong; Kwok-Hung Au; Roger K C Ngan; Sin-Ming Chow; Foon-Yiu Cheung; Yiu-Tung Fu; Joseph S K Au; Stephen C K Law
Journal:  Radiat Oncol       Date:  2011-05-21       Impact factor: 3.481

7.  Radiotherapy with fraction size of 2.25 Gy in T1-2 laryngeal and hypopharyngeal cancer.

Authors:  Kumiko Karasawa; Hiroaki Kunogi; Takahisa Hirai; Hidehiro Hoji; Hisako Hirowatari; Hiromi Izawa; Kana Ito; Keisuke Sasai; Tomohisa Furuya; Shuichi Ozawa; Fumihiko Matsumoto; Shin Ito; Shinichi Oba
Journal:  J Radiat Res       Date:  2013-01-07       Impact factor: 2.724

8.  Grade 3 radiation dermatitis in a patient with presumed latent actinic lichen planus.

Authors:  Scott R Silva; Bahman Emami
Journal:  Adv Radiat Oncol       Date:  2016-06-23

9.  Transoral laser surgery for recurrent glottic cancer after radiotherapy: oncologic and functional outcomes.

Authors:  F Del Bon; C Piazza; S Mangili; L O Redaelli De Zinis; P Nicolai; G Peretti
Journal:  Acta Otorhinolaryngol Ital       Date:  2012-08       Impact factor: 2.124

10.  Radiotherapy for T3N0 glottic carcinoma without cord fixation: elective nodal irradiation or not?

Authors:  Ryo Toya; Ryuji Murakami; Daizo Murakami; Tetsuo Saito; Tomohiko Matsuyama; Yutaka Toya; Yasuyuki Yamashita; Natsuo Oya
Journal:  Oncotarget       Date:  2017-07-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.